Generic Drug Executive Pleads Guilty To Restraint Of Trade
PHILADELPHIA — A senior executive for a New Jersey generic drug manufacturer on Feb. 14 pleaded guilty to one count of conspiracy to restrain trade for allegedly trying to rig the...To view the full article, register now.
Already a subscriber? Click here to view full article